Journal
New England Journal of Medicine
Publication Date
7-13-2023
Volume
389
Issue
2
First Page
148
Last Page
157
Document Type
Open Access Publication
DOI
10.1056/NEJMoa2301665
Rights and Permissions
Westin JR, Oluwole OO, Kersten MJ, Miklos DB, Perales MA, Ghobadi A, Rapoport AP, Sureda A, Jacobson CA, Farooq U, van Meerten T, Ulrickson M, Elsawy M, Leslie LA, Chaganti S, Dickinson M, Dorritie K, Reagan PM, McGuirk J, Song KW, Riedell PA, Minnema MC, Yang Y, Vardhanabhuti S, Filosto S, Cheng P, Shahani SA, Schupp M, To C, Locke FL; ZUMA-7 Investigators; Kite Members. Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma. N Engl J Med. 2023 Jul 13;389(2):148-157. doi: 10.1056/NEJMoa2301665. Copyright © 2023 Massachusetts Medical Society. Reprinted with permission.
Recommended Citation
Westin, Jason R; Ghobadi, Armin; and et al., "Survival with axicabtagene ciloleucel in large B-cell lymphoma." New England Journal of Medicine. 389, 2. 148 - 157. (2023).
https://digitalcommons.wustl.edu/oa_4/3523
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
